BioLife Solutions, Inc. (BLFS)
 NASDAQ: BLFS · Real-Time Price · USD
 26.90
 -0.64 (-2.32%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
BioLife Solutions Market Cap
BioLife Solutions has a market cap or net worth of $1.29 billion as of October 31, 2025. Its market cap has increased by 19.15% in one year.
Market Cap 
 1.29B
Enterprise Value 
 1.21B
1-Year Change 
 19.15%
Ranking 
 Category 
 Stock Price 
$26.90
Market Cap Chart
Since December 1, 1998, BioLife Solutions's market cap has increased from $4.30M to $1.29B, an increase of 29,868.64%. That is a compound annual growth rate of 23.59%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 1.32B | 9.56% | 
| Dec 31, 2024 | 1.20B | 68.30% | 
| Dec 29, 2023 | 715.50M | -8.07% | 
| Dec 30, 2022 | 778.30M | -49.86% | 
| Dec 31, 2021 | 1.55B | 18.87% | 
| Dec 31, 2020 | 1.31B | 294.62% | 
| Dec 31, 2019 | 330.90M | 48.65% | 
| Dec 31, 2018 | 222.60M | 172.13% | 
| Dec 29, 2017 | 81.80M | 295.17% | 
| Dec 30, 2016 | 20.70M | -22.18% | 
| Dec 31, 2015 | 26.60M | 34.34% | 
| Dec 31, 2014 | 19.80M | -53.08% | 
| Dec 31, 2013 | 42.20M | 78.06% | 
| Dec 31, 2012 | 23.70M | 577.14% | 
| Dec 30, 2011 | 3.50M | -16.67% | 
| Dec 31, 2010 | 4.20M | -45.45% | 
| Dec 31, 2009 | 7.70M | 266.67% | 
| Dec 31, 2008 | 2.10M | -50.00% | 
| Dec 31, 2007 | 4.20M | -12.50% | 
| Dec 29, 2006 | 4.80M | 220.00% | 
| Dec 30, 2005 | 1.50M | 36.36% | 
| Dec 31, 2004 | 1.10M | -21.43% | 
| Dec 31, 2003 | 1.40M | -6.67% | 
| Dec 31, 2002 | 1.50M | -42.31% | 
| Dec 31, 2001 | 2.60M | -57.38% | 
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 730.33B | 
| Johnson & Johnson | 449.57B | 
| AbbVie | 397.72B | 
| UnitedHealth Group | 321.75B | 
| AstraZeneca | 257.84B | 
| Novartis AG | 237.42B | 
| Novo Nordisk | 232.34B | 
| Abbott Laboratories | 216.57B |